Literature DB >> 35073631

A sinonasal yolk sac tumor in an adult.

Jaehoon Shin1, Ji Heui Kim2, Kyeong Cheon Jung3, Kyung-Ja Cho1.   

Abstract

Yolk sac tumors (YSTs), which are also called endodermal sinus tumors, are malignant tumors of germ cell origin. These tumors usually occur in the gonads, but 20% of cases have been reported at extragonadal sites. The head and neck is a rarely affected region that accounts for just 1% of all malignant tumors of germ cell origin. In addition, YSTs arise mostly in childhood. We present a rare pathologically pure case of primary adult YST in the sinonasal area. A 45-year-old male patient presented with a rapidly growing mass in the nasal cavity, which caused nasal obstruction and bloody post-nasal drip. The histopathologic features indicated pure YST, and immunohistochemical analysis revealed positive reactivity for Sal-like protein 4 and alpha-fetoprotein. Herein, we discuss the clinical, radiologic, and histologic features of this YST and review other cases of sinonasal YST in adults.

Entities:  

Keywords:  Adult; Endodermal sinus tumor; Nasal cavity; Paranasal sinus; Yolk sac tumor

Year:  2022        PMID: 35073631      PMCID: PMC9119804          DOI: 10.4132/jptm.2021.12.09

Source DB:  PubMed          Journal:  J Pathol Transl Med        ISSN: 2383-7837


Yolk sac tumors (YSTs), which are also called endodermal sinus tumors, are malignant tumors of germ cell origin. These tumors usually occur in the gonads, but 20% of cases have been reported at extragonadal sites. The head and neck is a rarely affected region that accounts for just 1% of all malignant tumors of germ cell origin [1]. In addition, YSTs arise mostly in childhood. To our knowledge, there are only eight reported cases of sinonasal YSTs in adult patients. We report a very rare case of a pathologically pure form of primary adult YST in the sinonasal area.

CASE REPORT

A 45-year-old man was referred to the Department of Otorhinolaryngology at Asan Medical Center in Seoul for persistent right nasal obstruction, bloody rhinorrhea, and post-nasal drip. He reported a history of bloody post-nasal drip for the past four months, facial pain for the last three months, visual disturbance in the right lower field, and diplopia. An endoscopic examination showed a 3-cm-sized mass obstructing the right nasal cavity with partially necrotic tissue. Initial computed tomography and magnetic resonance imaging revealed a mass that obstructed the right nasal cavity and caused bone destruction of the bilateral frontal and ethmoidal sinuses with intracranial extension. Destruction of the bilateral superomedial orbital wall and invasion of the right medial orbital wall and right nasolacrimal duct and sac were also identified (Fig. 1).
Fig. 1

Coronal (A) and transverse (B) magnetic resonance imaging shows a mass in the right nasal cavity and bilateral frontal sinus.

Endoscopic excisional biopsy was carried out. The specimen was removed in three pieces measuring up to 4 × 3 × 1.5 cm, with a pinkish brown color and a fleshy gelatinous texture. The submitted specimen was processed for histopathological examination and revealed typical YST features. The tumor showed mostly reticular and microcystic growth patterns with loose myxoid stroma, but there were also areas of glandular, solid sheet-like, and polyvesicular vitelline patterns. Some Schiller-Duval bodies were noted. Intra- and extra-cytoplasmic hyaline globules were identified (Fig. 2). No other tumor components were seen.
Fig. 2

Histopathologic findings of a sinonasal yolk sac tumor. (A) Reticular and microcystic growth patterns are observed with loose myxoid stroma. (B) A polyvesicular vitelline pattern is occasionally observed. (C) Schiller-Duval bodies are noted focally. (D) Intra- and extra-cytoplasmic hyaline globules are observed.

Immunohistochemical staining showed diffuse strong nuclear positivity for Sal-like protein 4 and diffuse strong cytoplasmic positivity for α-fetoprotein (Fig. 3). P40 was negative, but integrase interactor 1 (INI1) and Brahma-related gene-1 (BRG1) were both positive (Fig. 4). Therefore, the final diagnosis was pure YST. The patient was started on chemotherapy with a bleomycin, etoposide, and cisplatin regimen and palliative radiation therapy but showed a poor response. He died from the YST at 13 months after diagnosis.
Fig. 3

On immunohistochemical staining, the tumor cells show diffuse strong nuclear positivity for Sal-like protein 4 (A) and diffuse strong cytoplasmic positivity for α-fetoprotein (B).

Fig. 4

Immunohistochemical staining revealed that the tumor cells were negative for p40 (A) and diffusely positive for integrase interactor 1 (B) and Brahma-related gene-1 (C).

DISCUSSION

YST usually occurs in the gonads and is primarily found in infants and children. Extragonadal sites have included the sacrococcygeal region, retroperitoneum, mediastinum, brain, and very rarely, the head and neck area [2]. In addition, YST is usually accompanied by other germ cell tumor components, like teratoma or embryonal cell carcinoma. For example, the pure form YST of the testis accounts for just 2.4% of the reported adult testicular YSTs [3]. Definite diagnosis of YST can be made by biopsy. Upon microscopy, several histological patterns have been described. The most common is a reticular/microcystic pattern, which is a meshwork of anastomosing spaces and cysts lined by a single layer of tumor cells [4]. Other patterns include endodermal sinus, solid, myxomatous, papillary, glandular, macrocystic, and polyvesicular vitelline [4]. Our case demonstrated reticular, microcystic, and polyvesicular vitelline growth patterns and Schiller-Duval bodies. Shiller-Duval bodies are specific for YST, but they are not essential for diagnosis. The differential diagnoses of this case include sinonasal nonintestinal-type adenocarcinoma, SMARCB1-deficient sinonasal carcinoma with pure yolk sac differentiation, and SMARCA4-deficient teratocarcinosarcoma. Clear cytoplasm, an occasional fibrovascular core, and cytokeratin 7 negativity exclude sinonasal nonintestinal-type adenocarcinoma. SMARCB1-deficient sinonasal carcinoma usually shows high-grade histologic features, including prominent necrosis and mitoses, but relatively uniform cytology [5]. In our case, INI1 positivity excluded the possibility of SMARCB1-deficient sinonasal carcinoma with pure yolk sac differentiation, and BRG1 positivity ruled out the possibility of SMARCA4-deficient teratocarcinosarcoma. Eight adult-onset YSTs have been reported in the sinonasal area in the English literature (Table 1) [6-12]; four cases were accompanied by a transitional cell carcinoma component. Choriocarcinoma, poorly differentiated carcinoma, teratocarcinosarcoma, and SMARCB1 (INI1)-deficient carcinoma components were present in the remaining four cases, respectively. The reason for the common coexistence of a transitional cell carcinoma component in sinonasal YST remains uncertain. In our case, a transitional cell carcinoma component was not observed, as confirmed by p40 negativity. There are two theories about the origin of extragonadal YST. In the first theory, primordial germ cells are arrested or misplaced during migration from the cranial space to a gonadal site and consequently arrest in the cranial cavity [13]. The second theory holds that extragonadal tumors arise as a result of aberrant somatic differentiation [14]. Previous reports support the second theory. In contrast to previous cases, our case showed histologically pure YST features, which have never been reported. Our case therefore supports the first theory because its histologic features included pure YST not accompanied by other tumor components.
Table 1

Previously reported cases of adult-onset yolk sac tumor in the sinonasal area

No.Age (yr)/SexLocationFollow-upAssociated tumor componentsStudy
134/MNasopharynx1 yr (deceased)Transitional cell carcinomaManivel et al. [6]
243/MOrbit, maxillary, ethmoid and frontal sinuses1.5 yr (pulmonary metastasis)Transitional cell carcinomaManivel et al. [6]
348/MNasal cavity, ethmoid sinus, cribriform plate5 yr (disease-free)ChoriocarcinomaFilho et al. [7]
459/MOrbit, maxillary, ethmoid and frontal sinuses1 yr (disease-free)Poorly differentiated carcinomaMishra et al. [8]
551/FNasal cavity, cribriform plate, anterior cranial fossa, and frontal sinus-TeratocarcinosarcomaThomas et al. [9]
658/FNasal cavity, ethmoidal sinus, cribriform plate, and nasopharynx0.8 yr (disease-free)Transitional cell carcinomaMei et al. [10]
744/FNasal cavity, nasopharynx, ethmoid, sphenoid and maxillary sinuses-SMARCB1 (INI1) deficient carcinomaZamecnik et al. [11]
858/FNasal cavity, ethmoid sinus, nasopharynx3 yr (disease-free)Transitional cell carcinomaWang et al. [12]
945/MNasal cavity, orbit, frontal and ethmoidal sinuses13 mo (deceased)NonePresent case

INI1, integrase interactor 1.

Surgical resection, combined chemotherapy, and radiotherapy are available treatments for YST. Generally, YST is sensitive to chemotherapy. However, the head and neck region, including the sinonasal area as in our case, is very complex and difficult for R0 resection. As a result, the anatomic location seems to affect the prognosis, although the number of sinonasal YST cases is very small [15]. In addition, increasing age is known to negatively affect clinical behavior, and this trend is consistent with our case findings [16]. In conclusion, although adult-onset sinonasal pure YST is extremely rare, differential diagnosis is important. YST can present with many various scenarios in the sinonasal area, so YST should be considered if the clinical findings are histologically suspicious.
  16 in total

Review 1.  Congenital teratoma: a clinicopathologic study of 22 fetal and neonatal tumors.

Authors:  Amy Heerema-McKenney; Michael R Harrison; Barbara Bratton; Jody Farrell; Charles Zaloudek
Journal:  Am J Surg Pathol       Date:  2005-01       Impact factor: 6.394

2.  Pure yolk sac tumor of testis in an adult: a rare occurrence.

Authors:  S Khan; S Jetley; M Pujani; S Neogi
Journal:  J Postgrad Med       Date:  2014 Jul-Sep       Impact factor: 1.476

3.  A Case of Primary Sinonasal Yolk Sac Tumor.

Authors:  Peipei Wang; Guozhu Hou; Fang Li; Xin Cheng
Journal:  Clin Nucl Med       Date:  2020-11       Impact factor: 7.794

4.  SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.

Authors:  Abbas Agaimy; Arndt Hartmann; Cristina R Antonescu; Simion I Chiosea; Samir K El-Mofty; Helene Geddert; Heinrich Iro; James S Lewis; Bruno Märkl; Stacey E Mills; Marc-Oliver Riener; Thomas Robertson; Ann Sandison; Sabine Semrau; Roderick H W Simpson; Edward Stelow; William H Westra; Justin A Bishop
Journal:  Am J Surg Pathol       Date:  2017-04       Impact factor: 6.394

5.  Sinonasal yolk sac (Endodermal sinus) tumor in an adult female--A case report and review of the literature.

Authors:  Xianglin Mei; Yang Xia; Hironobu Sasano; Hongwen Gao
Journal:  APMIS       Date:  2015-06-11       Impact factor: 3.205

6.  Transitional (cylindric) cell carcinoma with endodermal sinus tumor-like features of the nasopharynx and paranasal sinuses. Clinicopathologic and immunohistochemical study of two cases.

Authors:  C Manivel; M R Wick; L P Dehner
Journal:  Arch Pathol Lab Med       Date:  1986-03       Impact factor: 5.534

7.  Germ cell tumors of the head and neck: report from the MAKEI Study Group.

Authors:  Beate Bernbeck; Dominik T Schneider; Benedikt Bernbeck; Susanne Koch; Carmen Teske; Jürgen Lentrodt; Dieter Harms; Ulrich Göbel; Gabriele Calaminus
Journal:  Pediatr Blood Cancer       Date:  2009-02       Impact factor: 3.167

8.  Endodermal sinus tumor of the paranasal sinuses.

Authors:  Anupam Mishra; Adel K El-Naggar; Franco DeMonte; Ehab Y Hanna
Journal:  Head Neck       Date:  2008-04       Impact factor: 3.147

9.  Somatically Derived Yolk Sac Tumor of the Ovary in a Young Woman.

Authors:  Anjelica Hodgson; Zeina Ghorab; Carlos Parra-Herran
Journal:  Int J Gynecol Pathol       Date:  2021-05-01       Impact factor: 2.762

Review 10.  Extragonadal germ cell tumors: Not just a matter of location. A review about clinical, molecular and pathological features.

Authors:  Andrea Ronchi; Immacolata Cozzolino; Marco Montella; Iacopo Panarese; Federica Zito Marino; Sabrina Rossetti; Paolo Chieffi; Marina Accardo; Gaetano Facchini; Renato Franco
Journal:  Cancer Med       Date:  2019-09-30       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.